この問題で

India's Foremost Pharma & Biotech Magazine ~ Rare Diseases: Awaiting Renewed Focus

RARE DISEASES AWAITING RENEWED FOCUS

India needs to make significant investments in R&D, policy reforms, and measures to enable affordability and accessibility of medicines and healthcare to manage the burden posed by rare diseases

10+ mins

E-Pharmacies – What Lies Ahead?

Dr Vikram A Munshi, Founder,WhiteSpace, Consulting and Capability Building discusses how e-pharmacies are faring in current times, their growth potential, and what their future beholds

3 mins

‘We may look at scaling to 50 per cent growth in the next financial year'

Manish Jain, Managing Director of Cilicant Chem, a company that provides solutions to protect highly moisture-sensitive products from the harmful effects of moisture or humidity for the desiccant market, discusses the company's growth strategy with Akanki Sharma

4 mins

Lonza India plans to double its turnover by 2024

Lonza is a global integrated solutions provider for pharma, consumer healthcare, and nutrition segments. Deepak Sood, MD, Lonza India talks about the company's plans for the Indian market, its strategic focus areas, and more in an exclusive interview with Express Pharma

4 mins

Atul Kumar Nasa awarded 'Schroff Memorial National Award, 2019'

The award was given by the Indian Hospital Pharmacists’Association in recognition of his contribution in strengthening the regulatory services

1 min

Ami Polymer signs master distribution agreement with Foxx Life Sciences

The Network allows full coverage of specialised Pharma Tubings (Platinum cured Silicone, TPE, FKM, and FEP tubings), O-rings, Manifolds, and Sanitary Gaskets for the markets such as Bio pharma, Medical and Lifesciences

1 min

Express Pharma の記事をすべて読む

Express Pharma Magazine Description:

Express Pharma formerly Express Pharma Pulse, one of the most widely read publication in pharmaceutical media since 1994, published by one of the oldest and most respected media group in India, the Indian Express Group. Express Pharma is India’s foremost Pharma & Biotech publication, published in a handy size and an international format, designed for readers convenience. Organized into four sections – Market, Management, Research and Pharma Life, it caters to the information needs of all levels of the pharmaceutical and biotech professionals. EP offers the widest geographic reach, focused business segment coverage and the sure means to reach the senior management and decision makers across the Industry.